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Abstract
Background: Livers of infants with biliary atresia and of neonatal mice infected with rotavirus
(RRV) have increased expression of interferon-gamma (IFNγ) and interleukin (IL)-12. While the
expression of IFNγ regulates the obstruction of extrahepatic bile ducts by lymphocytes, the role of
IL-12 in the pathogenesis of biliary obstruction is unknown. Based on the role of IL-12 as a key
proinflammatory cytokine, we hypothesized that loss of IL-12 prevents the obstruction of
extrahepatic bile ducts.
Methods: IL12-knockout (IL-12KO) and wild type mice were injected with RRV or saline at day 1
of age and monitored for the development of symptoms. The cellular and molecular phenotypes
were determined at days 3, 7, and 14 by real-time PCR and flow cytometry.
Results: RRV infection of IL-12KO mice resulted in growth failure, jaundice/acholic stools, and
decreased survival similar to wild-type mice. IL-12KO mice had a remarkable neutrophil-rich portal
inflammation and epithelial sloughing of extrahepatic bile ducts. Loss of IL-12 decreased but did not
abolish the hepatic expression of IFNγ, displayed a remarkable increase in expression of TNFα,
IFNα, IFNβ and decreased expression of IL-4 and IL-5.
Conclusion: Loss of IL-12 did not modify the progression of bile duct obstruction in experimental
biliary atresia. However, the inflammatory response was predominantly neutrophil-based and
displayed a Th1 response in the absence of IL-12.
Background
Elucidation of the molecular mechanisms regulating
injury and obstruction of extrahepatic bile ducts is critical
to understand the pathogenesis of biliary atresia, the most
common cause of pathological jaundice in infants. In bil-
iary atresia, the extrahepatic bile ducts undergo progres-
sive inflammatory and fibrosing obstruction, which
disrupts the lumenal continuity between the biliary tree
and the duodenum [1-3]. Although the etiology of the dis-
ease is undefined, the pathogenesis involves the interac-
tion of environmental and genetic factors that produce an
injury targeting the biliary tree. While the identification of
environmental agents in affected patients has varied
among different populations, analyses of liver samples
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port an important role for inflammatory cells in tissue
injury [3]. For example, CD4+ and CD8+ lymphocytes,
NK cells and activated macrophages infiltrate the hepatic
environment, populating primarily the portal system in
diseased tissues, in contrast to the lobular staining found
in liver samples from patients with other forms of neona-
tal cholestasis [4-8]. We recently investigated the tran-
scriptional program in livers of patients with biliary
atresia and found a unique footprint containing a signifi-
cant number of genes related to a proinflammatory activa-
tion of lymphocytes at the time of diagnosis, with an
increased expression of interferon-gamma (IFNγ) [9].
To directly investigate whether IFNγ played a key role in
pathogenesis of biliary injury, we first determined the
functional commitment of lymphocytes in the hepatobil-
iary system in a mouse model of rotavirus-induced biliary
atresia [9]. In these mice, inoculation of rhesus rotavirus
type A (RRV) soon after birth triggered a hepatobiliary
inflammation by CD4+ and CD8+ lymphocytes and an
overproduction of IFNγ. Then, we applied the same model
of rotavirus infection to mice deficient in IFNγ due to a
mutation in the IFNγ gene. We found that loss of IFNγ in
mice prevented the obstruction of the extrahepatic bile
ducts by inflammatory cells and maintained biliary conti-
nuity between the liver and duodenum [9]. Notably, loss
of IFNγ attenuated but did not abolish the hepatic infiltra-
tion of CD4+ and CD8+ lymphocytes and allowed for an
increase in interleukin (IL)-12 after RRV challenge. Based
on these data, on the synergistic role of IL-12 in the regu-
lation of the proinflammatory commitment of lym-
phocytes, and on the increase in IL-12 expression in livers
of children with biliary atresia [7], we hypothesized that
loss of IL-12 prevents duct obstruction in experimental
biliary atresia.
Methods
Mouse model of biliary atresia
Wild-type (WT) Balb/c mice were procured from Charles
River Laboratories Inc (Wilmington, MA, USA) and Balb/
c mice deficient in IL-12 due to the targeted disruption of
the IL-12p40 gene (IL-12KO) were procured from the
NIH-Taconic consortium. They were maintained in a spe-
cific pathogen-free vivarium and housed in a room with a
12-hour dark-light cycle. Within 24 hours of birth, mice
were injected with 0.9% saline solution (controls) or 1.5
× 106 fluorescence forming units (ffu) of RRV intraperito-
neally, as described previously [9-11]. Infected mice that
died within the first 2 days were excluded from further
analysis because early death is associated with complica-
tions of injection, such as intra-abdominal bleeding. All
mice were weighed daily, examined for the development
of icterus of the skin not covered with fur and for the
appearance of acholic stools, and sacrificed at 3, 7, and 14
days after saline or RRV challenge. The number of mice
used in each experiment and each time point is presented
in the Results section or in the tables/figure legends. The
Table 1: Primers used in real-time PCR to quantify levels of mRNA expression.
Primers Sequences
IFNγ Forward: 5'- GGCTGTCCCTGAAAGAAAGC -3'
Reverse: 5'- GAGCGAGTTATTTGTCATTCGG -3'
TNFα Forward: 5'- AAGGGAGAGTGGTCAGGTTGCC -3'
Reverse: 5'- CCTCAGGGAAGAGTCTGGAAAGG -3'
IFNα Forward: 5'- GACTTTGGATTTCCCCTGGAG -3'
Reverse: 5'- AAGCCTTTGATGTGAAGAGGTTC -3'
IFNβ Forward: 5'- GTTACACTGCCTTTGCCATCC -3'
Reverse: 5'- CAACAATAGTCTCATTCCACCCAG -3'
IL-4 Forward: 5'- CCACGGATGCGACAAAAATC
Reverse: 5'- TGTTCTTCGTTGCTGTGAGGAC
IL-5 Forward: 5'- TCCCTGCTACTCTCCCCAAAC
Reverse: 5'- TGGCACAGTCTGATTCATACATAGG
IL-18 Forward: 5'- AAATGGAGACCTGGAATCAGAC -3'
Reverse: 5'- TTTGTCAACGAAGAGAACTTGG -3'
IL-23 Forward: 5'-CCCGTATCCAGTGTGAAGATG -3'
Reverse: 5'- TGTCAGAGTCAAGCAGGTGC -3'
IL-27 Forward: 5'- TGTTCAAAGGAGGAGGAGGAC -3'
Reverse: 5'- GGATGACACCTGATTGGGG -3'
Rotavirus VP6 Forward: 5'- GCGGTAGCGGTGTTATTTCC -3'
Reverse: 5'- TTGTTTTGCTTGCGTCGG -3'
Rotavirus NSP3 Forward: 5'- TGTCAAGAGAATACCTGGGAAATC -3'
Reverse: 5'- GGAATCATCAACTTCAACTTCACC -3'
GAPDH Forward: 5'- TGGTTTGACAATGAATACGGCTAC
Reverse: 5'- GGTGGGTGGTCCAAGGTTTCPage 2 of 10
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Outcome of IL-12KO mice infected with RRVFigure 1
Outcome of IL-12KO mice infected with RRV. (A) Injection of RRV into newborn Balb/c mice leads to growth failure, as 
demonstrated by a significantly lower body weight when compared to non-infected mice (P < 0.05). RRV injection also leads to 
symptoms of cholestasis in mice between 4–8 days (B), and to decreased survival (C). The poor growth, onset of cholestasis, 
and decreased survival are similar to wild-type (WT) mice infected with RRV. Total number of animals at the time of injection 
of RRV or saline: IL-12KO-saline = 8, IL-12KO-RRV = 21, WT-RRV = 19. During the course of the study, all mice injected with 
normal saline remained healthy. In RRV injected IL-12KO mice, 20 out of 21 animal had died by day 17; similarly, 17 out of 19 
RRV infected WT mice had died by day 21.
BMC Gastroenterology 2006, 6:14 http://www.biomedcentral.com/1471-230X/6/14Institutional Animal Care and Use Committee (IACUC)
of the Cincinnati Children's Hospital Research Founda-
tion (Ohio, USA) approved all animal protocols.
Histopathology and gene expression
Livers and extrahepatic bile ducts were harvested from
neonatal mice at 3, 7 and 14 days following saline or RRV
using a dissecting microscope. Liver samples and the ext-
rahepatic bile ducts were fixed with formalin, paraffin-
embedded, sectioned with microtome (5-µm thickness),
and stained with H&E for microscopic analysis. Neighbor-
ing samples from the same livers were snap-frozen in liq-
uid nitrogen, and later used for RNA isolation with Trizol
(Invitrogen Life Technologies, Carlsbad, California, USA),
as described previously [9]. Quantification of RNA was
performed with a spectrophotometer, with purity and
integrity of RNA verified by 260/280 ratios and by agarose
gel electrophoresis.
Total RNA samples were treated with RNAse-free DNAse I
(Invitrogen Life Technologies, U.S.A.) to remove any con-
taminating genomic DNA. Reverse transcription was per-
formed with Superscript II reverse transcriptase and oligo
(dT)12–18 (Invitrogen) according to the manufacturer's
instructions. cDNA pools were subjected to real-time
kinetic PCR on a Mx-4000 Multiplex Quantitative PCR
(Stratagene, La Jolla, California, USA) using SYBR Green I
as a double-strand DNA-specific binding dye to quantify
mRNA expression for IL-12, IFN-γ, IFN-α, IFN-β, TNFα,
IL-4, IL-5, IL-18, IL-23, IL-27, RRV structural protein VP6,
and the nonstructural protein NSP3. PCR amplifications
were performed with specific primers outlined in Table 1
in a total volume of 20 µl containing 0.1 pmol of each
primer, 10 µl of 2× Brilliant SYBR QPCR master mix
(Stratagene), 3 nM of 1:500 diluted reference dye (ROX),
1 µl of 1:5 diluted cDNA and nuclease free water, after ini-
tial denaturation at 95°C and 40–45 cycles (95°C for 30
seconds, 55°C for 1 minute and 72°C for 30 seconds).
The levels of gene expression were calculated as a ratio to
glyceraldehyde-3-phosphate dehydrogenase (GAPDH), as
described previously [9].
Clearance of mRNA expression for viral proteinsFigure 3
Clearance of mRNA expression for viral proteins. The 
hepatic expression of mRNA encoding RRV nonstructural 
(panel A: NSP3) and structural (panel B: VP6) proteins in IL-
12KO mice was undetectable at days 3, high at day 7, and 
undetectable at day 14 after infection. P < 0.05; N = 4–6 mice 
per group at each time point.
RRV infection induces biliary inflammation in livers of IL-12KO miceFigure 2
RRV infection induces biliary inflammation in livers 
of IL-12KO mice. Infection of IL-12KO mice with RRV 
leads to minimal portal changes when compared to saline-
injected mice and RRV-infected wild-type (WT) within 3 days 
(panels A, B, C). In contrast, RRV induces a remarkable por-
tal expansion at 7 and 14 days in both IL-12KO and WT mice 
(panels E, F, H, I). Although the portal expansion has the 
same extent in both genotypes, IL12-KO livers have a mixed 
cellular infiltration with a predominance of neutrophils, while 
the portal spaces of WT livers contain primarily lymphocytes 
(insets in panels E, F, H, I). Arrows point to extramedullary 
hematopoiesis at day 3; N = 15–20 mice in each group; scale 
bar (left upper portion of each panel): 100 µ.Page 4 of 10
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Single cell suspensions of freshly harvested livers were
obtained from mice 14 days after RRV or saline injection
by mincing the livers, followed by passing through a
nylon mesh. Mononuclear cells were suspended in RPMI
Medium 1640 (Invitrogen, USA) and then centrifuged at
270 g for 10 minutes at 4°C. After lysis of the erythrocytes
with RBC lysis buffer (0.15 M NH4Cl, 10 mM KHCO3,
and 0.1 mM Na2EDTA, pH 7.2), cells were washed with
PBS supplemented with 3% fetal calf serum and counted
using a Neubauer chamber. Cells were stained by incuba-
tion with the following antibodies: anti-mouse CD3-
FITC, anti-mouse CD4-PE, anti-mouse CD8a-PE, and
anti-mouse neutrophil (CD11b-FITC and GR1-PE) (BD
Biosciences, San Jose, California, USA). Then, two-color
fluorometric analyses were performed in FACS buffer
(PBS containing 0.01% sodium azide and 2% {v/v} FCS)
as described previously [9]. Cells were then analyzed
using a FACSCalibur dual-laser flow cytometer (BD Bio-
sciences), with excitation at 488 and 633 nm. At least
150,000 events were acquired on the FACSCalibur for
each sample, with non-viable cells and cellular debris
excluded by forward and side scatter gating. Data were
analyzed using CellQuest software (BD Biosciences), as
described previously [9].
Statistical analysis
Values are expressed as mean ± SD, and statistical signifi-
cance was determined by unpaired t test between IL-12KO
mice injected with RRV or saline (controls) unless noted
otherwise, assuming normal distribution, with a signifi-
cance level of P < 0.05.
Results
Outcome of IL-12KO mice after RRV infection
Administration of 1.5 × 106 ffu of RRV intraperitoneally
into WT mice in the first 24 hours of life resulted in the
onset of jaundice and acholic stools within 1 week, with
impaired growth, and <10% survival beyond 3 weeks, as
described previously [9]. IL-12KO mice did not display
overt abnormalities after saline administration, grew well
during the suckling period and survived into adulthood.
In contrast, IL-12KO mice injected with RRV developed
jaundice and acholic stools within 1 week, had poor
growth, and only 10% survived beyond 3 weeks of life in
a fashion similar to the outcome of WT mice challenged
with RRV (Figure 1A–C). Collectively, these data demon-
strated that loss of IL-12 did not protect neonatal mice
from the development of progressive jaundice after RRV
infection.
Neutrophilic cholangiopathy in IL-12KO mice
To determine the cellular basis of progressive jaundice in
IL-12KO mice, we examined histological sections of livers
at 3, 7, and 14 days after saline or RRV administration.
Livers of IL-12KO mice injected with saline had normal
lobular architecture and residual extramedullary hemat-
opoiesis that is typically seen in the first few days of life
(Figure 2). Following RRV, however, IL-12KO mice dis-
played a mild periductal inflammation at 3 days, which
progressed to portal expansion by inflammatory cells and
duct profiles at 7 and 14 days. The inflammatory pattern
at 3 days was similar to that observed in livers of WT mice
injected with RRV (Figure 2). However, the cellular com-
ponents differed at days 7 and 14, with a mixed inflam-
matory infiltrate containing predominantly neutrophils
in IL-12KO mice, while lymphocytes were the predomi-
nant cell types in WT mice (Figure 2). To precisely deter-
mine the extent to which neutrophils infiltrate the portal
space of IL-12KO mice, we quantified T lymphocytes and
neutrophils by flow cytometry at 14 days after RRV chal-
lenge. We found that the total number of hepatic lym-
phocytes and neutrophils increased in IL-12KO mice
infected with RRV 2–4-fold above saline controls (Table
2). Interestingly, while the increase of CD3/CD4+ and
CD3/CD8+ cells was similar to WT mice infected with
Representative cross sections of extrahepatic bile ducts in IL-12KO miceFigure 4
Representative cross sections of extrahepatic bile 
ducts in IL-12KO mice. Panels A and B show the normal 
epithelium and unobstructed lumen at 7 and 14 days after the 
injection of saline in the first 24 hours of life. In contrast, the 
injection of RRV leads to an obstruction of the lumen by 
inflammatory cells at day 7, and by sloughed epithelial cells of 
cellular debris at 14 days (panels C, D). Scale bar: 100 µ.Page 5 of 10
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FITC and GR1-PE) in IL-12KO livers was greater than in
WT mice after RRV. The changes in the nature of the
inflammatory response induced by the loss of IL-12 did
not impair the ability of the mice to effectively clear RRV,
as demonstrated by the inability to detect the mRNA for
structural (VP6) and nonstructural (NSP3) proteins by
PCR 14 days after RRV challenge (Figure 3).
To directly determine whether RRV induced cholangiopa-
thy of the extrahepatic biliary tree in IL-12KO mice, we
analyzed serial sections of extrahepatic bile ducts 7 and 14
days after RRV challenge. These time points were chosen
because they have been reported to display a typical
inflammatory obstruction following RRV infection (at 7
days), followed by matrix components and minimal
inflammatory cells in atretic segments of bile ducts (at 14
days). We found obstruction of extrahepatic bile ducts in
IL-12KO mice (Figure 4). The segments of obstruction,
however, displayed ongoing epithelial injury and loss of
epithelial integrity, with areas of exfoliation and invasion
of the layer of cholangiocytes by neutrophils (Figure 5).
Altogether, these data suggest that the in vivo loss of IL-12
did not impair viral clearance nor modify the long-term
outcome of RRV-induced biliary atresia. However, the pre-
dominant neutrophilic infiltration suggested that neu-
trophils, rather than lymphocytes, may be the cellular
effectors of bile duct obstruction in IL-12KO mice.
Predominant expression of interferons and TNFα in IL-
12KO mice
To explore the potential mechanisms regulating the neu-
trophil-rich cholangiopathy and duct obstruction in IL-
12KO mice, we determined the hepatic mRNA expression
of the proinflammatory cytokines IFNγ and TNFα. Levels
of mRNA expression for both cytokines increased in RRV-
injected IL-12KO mice above controls (Figure 6A, B).
Interestingly, a comparison of the mRNA levels for IFNγ
following RRV challenge between IL-12KO and WT mice
demonstrated that the rise of IFNγ was higher in WT mice.
Neutrophil-rich biliary infiltration in IL-12KO miceFig e 5
Neutrophil-rich biliary infiltration in IL-12KO mice. Representative cross sections of extrahepatic bile ducts in IL-12KO 
mice 14 days after infection with RRV soon after birth show exfoliation and sloughing of the epithelium (short arrows), associ-
ated with an epithelial infiltration by neutrophils (arrows). Scale bar: 100 µ.
Table 2: Number (× 106 cells) of hepatic mononuclear cells 14 days after RRV challenge
Genotype Injection CD3/CD4+ CD3/CD8+ Neutrophils
IL-12KO Saline 0.26 ± 0.1 0.14 ± 0.03 0.39 ± 0.2
IL-12KO RRV 0.56 ± 0.1* 0.50 ± 0.2* 1.80 ± 0.01*@
Wild-type RRV 0.70 ± 0.03* 0.56 ± 0.2* 1.0 ± 0.2*
*P < 0.01 when compared to IL-12KO mice treated with saline.
@P < 0.05 when IL-12KO mice treated with RRV are compared to wild-type mice also treated with RRV.Page 6 of 10
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did not abolish the development of a Th1-like phenotype
in the hepatic environment. Based on a previous report
showing the role of type 1 interferons in generating a Th1
response in IL-12KO mice [12], we determined the expres-
sion of IFNα and IFNβ. We found that the hepatic levels
of mRNA expression for both cytokines in RRV-injected
IL-12KO mice increased significantly above levels of
saline-injected controls, with a peak expression at 7 days
that was similar to levels observed in RRV-infected WT
mice (Figure 6C, D). In contrast, the levels of mRNA
expression for the Th1 inducer cytokines IL-18 and the IL-
12 related cytokines IL-23 and IL-27 were either decreased
(for IL-18; Figure 7) or undetectable (for IL-23 and IL27;
data not shown) after RRV infection. The low levels of
expression for IL-18 support a lack of potential involve-
ment of IL-18 in the development of the Th1-like pheno-
type in IL-12KO mice. Interestingly, the hepatic
expression of prototype Th2 cytokines either decreased
(IL-4; P < 0.05) or did not change (IL-5) in IL-12KO mice
after RRV infection (Figure 7). This is consistent with a
dominant activation of proinflammatory cytokines in the
hepatic environment during the course of biliary injury
and obstruction.
Discussion
Despite the pivotal role of IL-12 as an innate cytokine and
a promoter of the Th1 response, the genetic loss of func-
tional IL-12 did not protect young mice from the develop-
ment of biliary obstruction after RRV challenge. Following
neonatal viral infection, IL-12-deficient mice developed
jaundice and acholic stools by 7 days of life, a time when
the liver underwent a remarkable expansion of inflamma-
tory infiltrate in the portal space. Although high levels of
structural and non-structural viral elements were detected
at this phase of injury, loss of IL-12 did not impair viral
clearance at later phases. The portal inflammation was of
mixed cellularity, with a remarkable presence of neu-
trophils at 7 and 14 days, which is in contrast to the pre-
dominantly lymphocytic infiltrate typically observed in
livers of wild-type mice at the same time points after RRV
infection. Notably, neutrophils also infiltrated the extra-
hepatic bile ducts, where they formed subepithelial clus-
ters or invaded the epithelium. These changes were clearly
associated with lumenal obstruction and interruption of
bile flow. While the loss of IL-12 did not modify the final
outcome of the inflammatory target and obstruction of
extrahepatic bile ducts, analysis of IL-12-deficient livers
identified two biological components with potential roles
in the regulation of neonatal cholangiopathy: 1) neu-
trophils as cellular effectors of duct injury, and 2) type-1
interferons as an alternate molecular circuit to induce a
proinflammatory microenvironment.
Neutrophils are key components of the initial inflamma-
tory response to tissue injury. In previous studies of exper-
imental biliary atresia, neutrophils accumulated near
intrahepatic bile ducts in early phases of liver injury after
RRV challenge, but became inconspicuous as the portal
inflammation expanded by the accumulation of lym-
phocytes, and bile ducts underwent obstruction by 7 days
[9]. In the current study, we found that this temporal
switch to a lymphocyte-rich population in the portal
spaces is controlled, at least in part, by IL-12, as demon-
strated by the contribution of neutrophils to the expan-
sion of the portal inflammation at 7 and 14 days (time of
bile duct obstruction), as well as by their presence near
and within injured epithelium of extrahepatic bile ducts.
These findings are of particular interest in view of the pre-
vious report of an increase in the number of neutrophils
when mice lacking IFNγ were subjected to the same model
of RRV-induced biliary atresia. Without IFNγ, the number
of hepatic neutrophils increased by 62% above non-trans-
genic littermates 7 days after RRV challenge [9]. However,
this increase was only transient and was not sufficient to
promote obstruction of bile ducts owing to a generalized
attenuation of the lymphocytic infiltration of extrahepatic
bile ducts in mice lacking IFNγ.
The differences in the outcome of biliary obstruction
between mice lacking IFNγ and IL-12 are probably due, at
least in part, to the combined effects of the neutrophilic
infiltration in IL-12 deficient mice through day 14 after
Expression of proinflammatory cytokines in IL-12KO miceFigure 6
Expression of proinflammatory cytokines in IL-12KO 
mice. RRV infection in the first day of life leads to an 
increased hepatic mRNA expression of IFNγ (A), TNFα (B), 
IFNα (C) and IFNβ (D) in IL-12KO mice above levels of 
saline-injected IL-12KO mice and WT mice injected with 
RRV. Also shown are the levels of expression. Levels of 
expression are shown as a ratio to GAPDH; *P < 0.05 for IL-
12KO mice injected with RRV vs saline; #P < 0.05 for IL-
12KO mice are compared to WT, both after RRV infection; 
N = 4–6 mice per group at each time point.Page 7 of 10
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expression of IFNγ. Although lower than the expression in
WT mice, the rise in IFNγ in IL-12-deficient mice was suf-
ficient to produce a Th1 pro-inflammatory response. Col-
lectively, these findings suggest that young mice activate
accessory molecular networks that trigger an increase in
IFNγ and maintain a neutrophil-rich mixed inflammatory
infiltration in the hepatobiliary system in the absence of
IL-12.
The production of IL-12 by phagocytic mononuclear cells
and dendritic cells is a key component of the molecular
networks that induce functional commitment of naïve
CD4 T lymphocytes to a Th1 proinflammatory phenotype
[13-15]. In keeping with this physiologic role, mRNA
expression of IL-12 increases remarkably after RRV infec-
tion [9]. Here, we show that such an increase is not essen-
tial for the expression of the proinflammatory response in
experimental biliary atresia, as demonstrated by the
increases in mRNA levels for IFNγ, and TNFα at the onset
of jaundice and acholic stools in mice lacking IL-12. The
increase in IFNγ mRNA, however, was of lower magnitude
when compared to the levels observed in wild-type mice
challenged with RRV. Although of lower magnitude, this
increase may have been sufficient to promote the obstruc-
tion of bile ducts in IL-12KO mice. Although IL-18, -23,
and -27 are candidate cytokines able to trigger the expres-
sion of IFNγ [16-19], we found no increase in their levels
of mRNA expression in livers of IL-12 deficient mice.
Interestingly, the lack of expression of IL-23 and -27 are in
accordance with the requirement of p40 as a critical subu-
nit to form functional heterodimers with p19 (to generate
IL-23) and p28 (for IL-27; p40 shares high homology to
the EB12 subunit). Thus, the loss of IL-23 and -27 induced
by the deficiency of p40 disrupts the network among these
related cytokines. Despite this disruption, the injury and
obstruction of extrahepatic bile ducts proceeded in a
timely fashion, albeit with different cellular components.
This may have been facilitated by type I interferons, as
supported by the increase in the mRNA levels for IFNα
and IFNβ in IL-12-deficient mice. Collectively, these data
are consistent with a biological setting in which type-1
interferons work independently of IL-12 to induce the
expression of IFNγ and other Th1 proinflammatory
cytokines after RRV challenge. A similar biological setting
was previously demonstrated in IL-12-deficient mice sub-
jected to lymphocytic choriomeningitis virus infection
[20]. Direct proof that an IFNα/β-dependent circuit regu-
lates induction of IFNγ and duct obstruction in IL-12KO
mice will require the analysis of the biliary phenotype fol-
lowing the in vivo inactivation of type-1 interferons in the
same experimental model.
Conclusion
The genetic loss of functional IL-12 in vivo does not pro-
tect neonatal mice from an inflammatory-driven injury
and obstruction of extrahepatic bile ducts after a viral
insult. However, the inflammatory response displayed a
Expression of IL-18 and Th2 cytokines in IL-12KO miceFigure 7
Expression of IL-18 and Th2 cytokines in IL-12KO 
mice. RRV infection in the first day of life leads to a decrease 
in the hepatic mRNA expression of IL-18 (A) and IL-4 (B), 
with no changes in IL-5 mRNA (C). Levels of expression are 
shown as a ratio to GAPDH; *P < 0.05; N = 4–6 mice per 
group at each time point.Page 8 of 10
(page number not for citation purposes)
BMC Gastroenterology 2006, 6:14 http://www.biomedcentral.com/1471-230X/6/14persistent neutrophilic response and a gradual rise in the
expression of type-1 interferons at the time of duct
obstruction. Exogenous administration of IFNα before or
at the time of RRV challenge was previously reported to
significantly alleviate the progression of jaundice and
cholestasis in this mouse model of bile duct obstruction
[21]. In these experiments, however, the authors did not
examine the impact of RRV challenge or administration of
IFNα on the native production of type-1 or -2 interferons,
or on other molecules that may regulate biliary injury and
obstruction. In this context, the findings in IL-12KO mice
presented herein further underscore the importance of
future studies to address the independent or synergistic
roles of type-1 interferons and neutrophils in the develop-
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